Stille to release Q3 2026 interim results on October 23

what happened

Stille AB (publ) has confirmed that its Q3 2026 interim results are scheduled for release on October 23, with publication set for 8 a.m. CET. The date was flagged earlier, and this reminder reached readers through the Newsmetry API feed.

A web-cast presentation and question-and-answer session follow at 2 p.m. CET the same day. Chief Executive Ulrik Berthelsen and Chief Financial Officer Niklas Tyrén will speak to analysts, investors and members of the press. Attendance requires advance registration, after which participants receive dial-in details. Questions can be submitted over the phone or through the audio stream.

Stille, founded in 1841, develops, manufactures and distributes premium surgical instruments and advanced operating tables. Its stock is quoted on the Nasdaq First North Growth Market, symbol STIL, and Eminova AB serves as its Certified Adviser.

why it matters

For investors, the date is a fixed point on the reporting calendar, since quarterly figures from a premium surgical niche can shift expectations for sales and profitability. The notice itself contains no financial data, so it should be read as a scheduling update rather than a signal about results.

tags

instruments